Pathogenic mechanisms of neurodegeneration in Parkinson disease

Neurol Clin. 2015 Feb;33(1):1-17. doi: 10.1016/j.ncl.2014.09.010.

Abstract

The last 2 decades represent a period of unparalleled advancement in the understanding of the pathogenesis of Parkinson disease (PD). The discovery of several forms of familial parkinsonism with mendelian inheritance has elucidated insights into the mechanisms underlying the degeneration of dopaminergic neurons of the substantia nigra that histologically characterize PD. α-Synuclein, the principal component of Lewy bodies, remains the presumed pathogen at the heart of the current model; however, concurrently, a diverse range of other mechanisms have been implicated. The creation of a coherent disease model will be crucial to the development of effective disease modifying therapies for sporadic PD.

Keywords: Lewy bodies; Mitochondrial dysfunction; Parkinson disease; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glucosylceramidase / metabolism
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Mutation / genetics
  • Nerve Degeneration / etiology*
  • Parkinson Disease / complications*
  • Parkinson Disease / genetics*
  • Protein Serine-Threonine Kinases
  • Substantia Nigra / metabolism
  • Substantia Nigra / pathology
  • alpha-Synuclein / genetics
  • alpha-Synuclein / metabolism*

Substances

  • SNCA protein, human
  • alpha-Synuclein
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
  • Glucosylceramidase